On this ALCSI podcast, Mrs. Kerrie Mitchell talks about her personal journey being diagnosed with stage IV NSCLC with metastasis to lymph nodes and the brain. She describes receiving Cyberknife to the brain and the side effects she faced as a result of the treatment. As a resident of the UK, she also talks about similarities and differences in lung cancer screening between the UK and US.
Kerrie was 45 when she was given her diagnosis. She had no symptoms other than a lump on her neck, which she had checked out by a GP. Kerrie is a wife, a mum of one daughter and continues to work full time. Almost 3 years after diagnosis, and after treatment of immunotherapy, a chemotherapy regime, and Cyberknife to the brain, Kerrie is currently ‘no evidence of active disease’. Kerrie is currently living a full life and working with others to support and raise awareness of lung cancer, particularly among younger women whilst trying to remove the stigma around smoking, as one just needs lungs to get lung cancer.
Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, thousands of lives could be saved this year alone. However, less than 6% of high-risk Americans are currently getting screened. Visit our website at https://www.alcsi.org/ for free educational resources and webinars on lung cancer and lung cancer screening.